Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.

Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.

Item
http://www.wikidata.org/entity/Q35012803
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examplesHow I manage cerebral vasculopathy in children with sickle cell disease.Recent advances in childhood arterial ischemic strokeEffects of chronic transfusions on abdominal sonographic abnormalities in children with sickle cell anemiaHow I treat and manage strokes in sickle cell disease.Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents.Neurological Complications following Blood Transfusions in Sickle Cell Anemia.Optimal Manual Exchange Transfusion Protocol for Sickle Cell Disease: A Retrospective Comparison of Two Comprehensive Care Centers in the United Kingdom and Canada.Chronic blood transfusion for primary and secondary stroke prevention in Nigerian children with sickle cell disease: a 5-year appraisal.Chronic transfusion practices for prevention of primary stroke in children with sickle cell anemia and abnormal TCD velocities.
P2860

Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.

Item
http://www.wikidata.org/entity/Q35012803
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Feasibility and efficacy of ch ...... dren with sickle cell disease.
@ast
Feasibility and efficacy of ch ...... dren with sickle cell disease.
@en
type
label
Feasibility and efficacy of ch ...... dren with sickle cell disease.
@ast
Feasibility and efficacy of ch ...... dren with sickle cell disease.
@en
prefLabel
Feasibility and efficacy of ch ...... dren with sickle cell disease.
@ast
Feasibility and efficacy of ch ...... dren with sickle cell disease.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Feasibility and efficacy of ch ...... dren with sickle cell disease.
@en
P2093
P304
P31
P356
10.1111/J.1600-0609.2009.01379.X
P433
P478
P577
P698
P921